Telix Pharmaceuticals Limited (TLX)
NASDAQ: TLX · Real-Time Price · USD
9.56
+0.11 (1.16%)
Jun 12, 2026, 4:00 PM EDT - Market closed
Telix Pharmaceuticals Market Cap
Telix Pharmaceuticals has a market cap or net worth of $3.26 billion as of June 12, 2026. Its market cap has decreased by -43.09% in one year.
Market Cap
3.26B
Enterprise Value
3.60B
1-Year Change
-43.09%
Ranking
Category
Stock Price
$9.56
Market Cap Chart
Since November 15, 2017, Telix Pharmaceuticals's market cap has increased from $115.28M to $3.26B, an increase of 2,724.02%. That is a compound annual growth rate of 47.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 12, 2026 | 3.26B | 28.65% |
| Dec 31, 2025 | 2.53B | -50.36% |
| Dec 31, 2024 | 5.10B | 129.18% |
| Dec 29, 2023 | 2.22B | 42.30% |
| Dec 30, 2022 | 1.56B | -2.70% |
| Dec 31, 2021 | 1.61B | 96.45% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Nov 15, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ACADIA Pharmaceuticals | 3.61B |
| NewAmsterdam Pharma Company | 3.55B |
| Denali Therapeutics | 3.44B |
| Viking Therapeutics | 3.34B |
| Relay Therapeutics | 3.23B |
| Alumis | 3.08B |
| Structure Therapeutics | 3.05B |
| Arcutis Biotherapeutics | 3.05B |